跳至主要内容
临床试验/CTRI/2025/02/081333
CTRI/2025/02/081333尚未招募3 期

Randomised open controlled clinical study to evaluate the efficacy of Navakarshik ghanvati in vatarakta w s r to Gout

Dr Krishna Punasing Pawar1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2025年3月5日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
80
试验地点
1
主要终点
To study the efficacy of Nawakarshika ghanvati in vatarakta.

研究概览

简要总结

RANDOMISED OPEN CONTROLLED CLINICAL STUDY TO EVALUATE

THE EFFICACY OF NAVAKARSHIK GHANAVATI IN VATRAKTA W.S.R. TO GOUT.

The assesment of signs and symptoms will be done at regular follow ups.

Observation will be drawn from the outcomes achieved in 30 days .

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
20.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Patient presenting Toda Shotha and Sthabdhata in relation to Parvasandhi Patients having serum uric acid level more than 7mg/dl in male and more than 6mg/ dl in female.

排除标准

  • Known case of Amavata Sandhigatvata SLE Patient on chronic use of NSAIDS and steroidal inflammatorydrugs Pregnancy Lactating mothers Patients prediagnosed with autoimmune diseases of joint Patients with severe toxicity, ulceration, progressive gangrenous changes, and suffering from diseases of immunological basis.
  • Patients associated with metabolic disorders and systemic diseases.

结局指标

主要结局

To study the efficacy of Nawakarshika ghanvati in vatarakta.

时间窗: 30 days

次要结局

  • To reduce the signs and symptoms of Vatarakta.(To assess the improvement by signs, symptoms and gradation of assessment criteria.)

研究者

发起方
Dr Krishna Punasing Pawar
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Krishna Punasing pawar

Yashwant Ayurvedic College Post Graduate Training and Research Centre Kodoli

研究点 (1)

Loading locations...

相似试验